We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Expert Opinion / Interview · October 31, 2018

ESMO 2018: Weekly Paclitaxel Plus Bevacizumab for Relapsed Ovarian Sex Cord Tumors

Interview by
Sumanta Kumar Pal MD
Interview with
Susana N. Banerjee PhD, MBBS


Additional Info

Disclosure statements are available on the authors' profiles:

Further Reading